Additionally, the researchers observed a synergistic interaction between elevated serum MSTN levels and baseline loss of skeletal muscle in RA patients [347], which could be used to predict the progression of radiographic joint injury over one year. This evidence concerns the gene MSTN and rheumatoid arthritis.